{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:12:10Z","timestamp":1791331930410,"version":"4.3.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:00:00Z","timestamp":1308873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021203","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T16:57:15Z","timestamp":1308934635000},"page":"e21203","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML"],"prefix":"10.1371","volume":"6","author":[{"given":"Kalpana","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabha","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Ramdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munna L.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia.","volume":"368","author":"E Estey","year":"2006","journal-title":"Lancet"},{"key":"ref2","year":"2006"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/14728214.9.1.55","article-title":"Emerging treatments in acute myeloid leukaemia.","volume":"9","author":"J Kell","year":"2004","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref4","first-page":"S81","article-title":"Curative therapeutic approaches to APL.","volume":"83","author":"MS Tallmann","year":"2004","journal-title":"Ann Hematol"},{"key":"ref5","first-page":"11","article-title":"[Pharmacology of a new alkaloid securinine.].","volume":"19","author":"A IaA","year":"1956","journal-title":"Farmakol Toksikol"},{"key":"ref6","author":"J Duke","year":"1985"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(85)90014-9","article-title":"Securinine alkaloids: a new class of GABA receptor antagonist.","volume":"330","author":"JA Beutler","year":"1985","journal-title":"Brain Res"},{"key":"ref8","first-page":"7","article-title":"[Result of application of securinine in acute poliomyelitis.].","volume":"21","author":"GR Buravtseva","year":"1958","journal-title":"Farmakol Toksikol"},{"key":"ref9","first-page":"36","article-title":"From Asia securinine\u2013a central nervous stimulant is used in treatment of amytrophic lateral sclerosis.","volume":"76","author":"R Copperman","year":"1973","journal-title":"Pa Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.1974.03230280016013","article-title":"Letter: Securinine.","volume":"228","author":"R Copperman","year":"1974","journal-title":"Jama"},{"key":"ref11","first-page":"267","article-title":"Securinine induced apoptosis in human leukemia HL-60 cells.","volume":"20","author":"NZ Dong","year":"1999","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"ref12","article-title":"Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells.","author":"S Rana","year":"2010","journal-title":"FASEB J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1189\/jlb.0407255","article-title":"Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists.","volume":"82","author":"K Lubick","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1084\/jem.149.4.969","article-title":"Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.","volume":"149","author":"SJ Collins","year":"1979","journal-title":"J Exp Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1083\/jcb.82.2.315","article-title":"Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation.","volume":"82","author":"PE Newburger","year":"1979","journal-title":"J Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ijc.2910250208","article-title":"Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells.","volume":"25","author":"SJ Collins","year":"1980","journal-title":"Int J Cancer"},{"key":"ref17","first-page":"183","article-title":"[The nitroblue tetrazolium activated test in the study of granulocytic function. Proposed methodology].","volume":"56","author":"P Guglielmo","year":"1980","journal-title":"Boll Soc Ital Biol Sper"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1016\/S0021-9258(17)43161-9","article-title":"Development of the superoxide-generating system during differentiation of the HL-60 human promyelocytic leukemia cell line.","volume":"259","author":"PE Newburger","year":"1984","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1158\/0008-5472.CAN-07-6559","article-title":"Identification of 6-benzylthioinosine as a myeloid leukemia differentiation-inducing compound.","volume":"68","author":"DN Wald","year":"2008","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.molimm.2005.07.025","article-title":"Human peripheral blood mononuclear cells express GABAA receptor subunits.","volume":"43","author":"S Alam","year":"2006","journal-title":"Mol Immunol"},{"key":"ref21","first-page":"157","article-title":"Pharmacological investigations of virosecurinine.","volume":"18","author":"L Hill","year":"1976","journal-title":"P N G Med J"},{"key":"ref22","first-page":"278","article-title":"[Pharmacological comparison between virosecurinine and securinine].","volume":"24","author":"H Pu","year":"2001","journal-title":"Zhong Yao Cai"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1096\/fj.09-148999","article-title":"Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells.","volume":"24","author":"S Rana","year":"2010","journal-title":"FASEB J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e7768","DOI":"10.1371\/journal.pone.0007768","article-title":"Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy.","volume":"4","author":"M Meyer","year":"2009","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/sj.leu.2401228","article-title":"p21Cip1\/WAF1 is important for differentiation and survival of U937 cells.","volume":"12","author":"M Asada","year":"1998","journal-title":"Leukemia"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T07:41:56Z","timestamp":1637912516000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021203"}},"subtitle":[],"editor":[{"given":"John D.","family":"Minna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,24]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021203","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,24]]}}}